[1]
Moryl, MD, N., Filkins, A., Griffo, MD, Y., Malhotra, MD, V., Jain, R.H., Frierson, RN, BSN, OCN, E. and Inturrisi, PhD, C. 2020. Successful use of buprenorphine-naloxone medication-assisted program to treat concurrent pain and opioid addiction after cancer therapy. Journal of Opioid Management. 16, 2 (Mar. 2020), 111–118. DOI:https://doi.org/10.5055/jom.2020.0557.